Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Sandu Pharmaceuticals Ltd

Your Vote -

Buy

33.33%

Hold

33.33%

Sell

33.33%

33.33%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Sandu Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sandu Pharmaceut - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jan 2026, 10:14AM Certificate under Regulation 74(5) of SEBI (DP) Regulation 2015 for Q ended 31.12.2025
  • Sandu Pharmaceut - Announcement Under Regulation 30-Notice Intimating Discrepancies By Government Of Maharashtra Department O

    22 Dec 2025, 9:56PM intimation about the Notice Pertaining to discrepancies by Government of Maharashtra department of Goods and service Tax
  • Sandu Pharmaceut - : Intimation Regarding Receipt Of Approval Of Shareholders For Reclassification Of M/S Akshath Finvest An

    19 Nov 2025, 3:24PM Postal Ballot approval on reclassification of Promoter into Public
  • Sandu Pharmaceut - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    19 Nov 2025, 3:21PM Scrutinizers report inrespect of Postal ballot for reclassification of M/s Akshath Finvest and Properties Private Limited from Promoter Group Categor
  • Sandu Pharmaceut - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    19 Nov 2025, 3:18PM Outcome of the Postal Ballot pertaining to reclassification of M/s Akshath Finvest and Properties Private Limited from Promoter Group category to Publ
  • Sandu Pharmaceut - Statement Of Deviation And Variation For The Quarter Ended 30.09.2025

    12 Nov 2025, 6:03PM statement of deviation and variation for the quarter ended 30.09.2025
  • Sandu Pharmaceut Q2 net profit up 4.00% at Rs 0.52 cr

    12 Nov 2025, 5:52PM The company reported standalone net profit of Rs 0.52 crore for the quarter ended September 30, 2025 as compared to Rs 0.50 crore in the same period l
  • Sandu Pharmaceut - Unaudited Financial Results For The Q And Half Year Ended 30.09.2025

    12 Nov 2025, 5:51PM unaudited financial results for q and year ended 30.09.2025
  • Sandu Pharmaceut - Board Meeting Outcome for Outcome Of The Board Meeting Dated 12.11.2025

    12 Nov 2025, 5:43PM outcome of the Board Meeting
  • Sandu Pharmaceut - Board Meeting Intimation for Approval Of Standalone Unaudited Financial Results For Quarter And Half Year

    5 Nov 2025, 3:36PM Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to conside
  • Sandu Pharmaceut has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    17 Oct 2025, 3:20PM As of September 2025, 42.91% is owned by Indian Promoters and 57.10% by Public. <p align=justify> Top five Promoters holding highest number of shares
  • Sandu Pharmaceut - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    17 Oct 2025, 12:41PM notice of the Postal Ballot to obtain shareholders approval for Reclassification of Akshath Finvest and Properties Private Limited from Promoter/Prom
  • Sandu Pharmaceut - Approval Of The Draft Postal Ballot Notice And Explanatory Statement

    14 Oct 2025, 12:50PM Approval of the Draft Postal Ballot Notice and Explanatory Statement
  • Sandu Pharmaceut - Board Meeting Outcome for Outcome Of The Board Meeting Dated 14Th October 2025

    14 Oct 2025, 12:46PM 1.Approval of Postal Ballot Notice and Explanatory Statement\r\n2.Fixing of Cut off date for postal ballot

Key fundamentals

Evaluate the intrinsic value of Sandu Pharmaceuticals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 42.0172 40.5953 39.2444 36.4746 33.5104
Liabilities 42.0172 40.5953 39.2444 36.4746 33.5104
Equity 9.661 9.661 9.661 8.8107 7.9209
Gross Profit 2.7622 2.2973 2.4893 2.874 2.159
Net Profit 1.5489 1.4606 1.5239 1.5893 1.0924
Cash From Operating Activities 0.9504 0.7614 0.2212 0.9487 7.59
NPM(%) 2.3 2.17 2.33 2.42 1.85
Revenue 67.1924 67.2807 65.349 65.5005 58.7554
Expenses 64.4302 64.9834 62.8597 62.6265 56.5963
ROE(%) 3.79 3.57 3.73 3.89 2.67

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sandu Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 744.00 -0.27 0.00 22.90 301.39 0.68
Lotus Eye Hospital and Institute Ltd 113.60 -4.98 348.69 83.46 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 18.68 -3.51 0.00 173.28 -39.50 0.00
Astec Lifesciences Ltd 639.60 -3.63 0.00 78.70 -604.77 0.00

Company Info

The name "Sandu" leads in this roll call of honour. 10th May 1899 was the day Sandu Brothers chose to revolutionise the manufacture of Ayurvedic medicines. Commitment to the spread of Ayurveda and bringing health even to the poor were the lofty ideals that have been the foundation of the success of Sandu. High quality made Sandu medicines popular. Started on 10th May 1899 at Thakurdwar, Mumbai, the factory was later shifted to Chembur to cater to growing demand. Sandu is now a name established throughout India and has earned acceptance even beyond its borders and not in the Indian diaspora alone. Over 120 years, the secret of Sandu's success lies in our commitment to quality and firm adherence to the basic tenets of Ayurveda. Today, the fourth generation of Sandu at the helm implements a seamless confluence between tradition and modern pharmaceutical practices. We are growing, but without compromising on the quality in any way.Sandu is a benchmark of Quality amongst doctors, practitioners, and common people alike. Our commitment to quality is reflected in the ISO 9001:2000 certification we have earned for our Group operations which include our manufacturing units at New Mumbai and Goa as well as our full-fledged research unit - Sandu Research Foundation Pvt Ltd. While we rigorously follow traditional formulations, our manufacturing processes are totally aseptic and state-of-the-art with no human contact during the manufacturing process. Today, when allopathic medicines dominate the market, Sandu takes deserved pride in being known as the manufacturer of Ayurvedic Medicines with Visible Efficacy.

The name "Sandu" leads in this roll call of honour. 10th May 1899 was the day Sandu Brothers chose to revolutionise the manufacture of Ayurvedic medicines. Commitment to the spread of Ayurveda and bringing health even to the poor were the lofty ideals that have been the foundation of the success of Sandu. High quality made Sandu medicines popular. Started on 10th May 1899 at Thakurdwar, Mumbai, the factory was later shifted to Chembur to cater to growing demand. Sandu is now a name established throughout India and has earned acceptance even beyond its borders and not in the Indian diaspora alone. Over 120 years, the secret of Sandu's success lies in our commitment to quality and firm adherence to the basic tenets of Ayurveda. Today, the fourth generation of Sandu at the helm implements a seamless confluence between tradition and modern pharmaceutical practices. We are growing, but without compromising on the quality in any way.Sandu is a benchmark of Quality amongst doctors, practitioners, and common people alike. Our commitment to quality is reflected in the ISO 9001:2000 certification we have earned for our Group operations which include our manufacturing units at New Mumbai and Goa as well as our full-fledged research unit - Sandu Research Foundation Pvt Ltd. While we rigorously follow traditional formulations, our manufacturing processes are totally aseptic and state-of-the-art with no human contact during the manufacturing process. Today, when allopathic medicines dominate the market, Sandu takes deserved pride in being known as the manufacturer of Ayurvedic Medicines with Visible Efficacy.

Read More

Parent Organisation

Sandu Pharmaceuticals Ltd.

Founded

15/11/1985

Managing Director

NSE Symbol

FAQ

The current price of Sandu Pharmaceuticals Ltd is

The 52-week high for Sandu Pharmaceuticals Ltd is

The market capitalization of Sandu Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Sandu Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Sandu Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sandu Pharmaceuticals Ltd shares.

The CEO of Sandu Pharmaceuticals Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT